Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
WuXi Biologics (Shanghai) Co., Ltd. Removed from the U.S. Commerce Department's Unverified List 2022-12-16 08:44
Bioved Pharmaceuticals, Inc. announces the results of its Phase III Randomized Clinical Trial in Moderate Covid-19 with Artovid-20®, a natural plant-based oral product 2022-12-16 01:30
China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19 2022-12-15 21:00
Nevisense for skin barrier evaluation included in large Australian birth cohort study 2022-12-15 15:50
Pharming announces positive interim analysis data from open-label extension study of leniolisib in presentation at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition 2022-12-15 14:00
IND Application of Biosyngen's Cell Therapy (BRG01) for Nasopharyngeal Cancer Approved by China NMPA 2022-12-15 13:08
"Gowajee" - a Thai Speech-Recognition AI from Chula 2022-12-15 09:00
Innovent and LG Chem Announce Strategic Collaboration for Tigulixostat, a Novel Non-Purine Xanthine Oxidase Inhibitor for the Treatment of Gout Disease 2022-12-15 08:00
Alternative Bio Launches with USD 15M Series Seed Financing Led by Eight Roads Ventures with F-Prime Capital and Sequoia China Seed Fund 2022-12-15 08:00
Everest Medicines Announces New mRNA Rabies Vaccine Program and Achievement of Preclinical Proof-of-Concept Milestone 2022-12-15 08:00
Sirnaomics Announces Positive Interim Data from Phase IIb Clinical Trial of STP705 in Adults with Cutaneous Squamous Cell Carcinoma In Situ 2022-12-14 23:47
Actinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trial 2022-12-14 21:52
E-Home Household Services Holdings Limited's subsidiary Zhong Run Launches Cloud Pharmacy Service to Address New Situation of Epidemic Prevention and Control 2022-12-14 21:30
Hovione and GEA announce a strategic collaboration to advance Continuous Tableting 2022-12-14 21:00
Superior Results Of The Comparative Study Of The Company's Recombinant Two-Component COVID-19 Vaccine ReCOV As Compared To International Mainstream mRNA Vaccine 2022-12-14 15:17
Sirnaomics Executive Director Dr. Xiaochang Dai to Deliver Keynote Speech at BIOHK2022 2022-12-14 01:41
Sirnaomics Executive Director Dr. Xiaochang Dai to Deliver Keynote Speech at BIOHK2022 2022-12-14 01:40
Treadwell Therapeutics Announces A Presentation at the 2022 ASH Annual Meeting Featuring a Clinical Trial Update on CFI-400945, an oral PLK4 inhibitor 2022-12-13 22:30
HistoSonics Announces $100 Million in Financings and New Appointment to its Board of Directors 2022-12-13 20:00
Biosion Announces Research Collaboration with ImmunoGen to Create Novel Antibody-Drug Conjugates 2022-12-13 18:00
1 94 95 96 97 98 375